GIIGX Gabelli International Growth I Forecast, Technical & Fundamental Analysis

The most notable companies in this group are AstraZeneca PLC (NASDAQ:AZN).

The investment seeks long-term capital appreciation. The fund normally invests at least 65% of its total assets in equity securities of foreign issuers located in at least three countries outside the United States that the fund's investment adviser believes are likely to have rapid growth in revenues and earnings and potential for above-average capital appreciation. The advisor intends to invest in the securities of companies located in developed countries and, to a lesser extent, those located in emerging markets.

The average market capitalization across the Gabelli International Growth I MF is 131.2B. The market cap for tickers in the group ranges from 154.08M to 327.81B. NSRGF holds the highest valuation in this group at 327.81B. The lowest valued company is CDI at 154.08M.

The average weekly volume growth across all stocks in the Gabelli International Growth I MF was 21%. For the same stocks of the MF, the average monthly volume growth was -28% and the average quarterly volume growth was -9%